Literature DB >> 19120099

Effects of acute and chronic stressors and CRF in rat and mouse tests for depression.

Adrian J Dunn1, Artur H Swiergiel.   

Abstract

Depressive illness is frequently associated with life stress. Corticotropin-releasing factor (CRF) is believed to be a key brain mediator of behaviors associated with stress, and abnormalities in the function of CRF have been associated with depression. Therefore, we have studied the effects of acute and chronic footshock and restraint in tests used in rodents to assess depression-like activity and antidepressant effects: the forced swim test in rats and mice, and the tail suspension test in mice. We also tested the effect of intracerebroventricular (icv) CRF administration. The results were complex. In the forced swim test in rats, acute footshock and restraint reduced floating, whereas chronic footshock increased floating as did icv CRF. However, chronic restraint induced opposite effects, decreasing floating in the forced swim test. The results from mice were significantly different. In the forced swim test, acute footshock and restraint decreased floating, while chronic footshock increased floating, and chronic restraint decreased floating as it did in rats. However, icv CRF decreased floating. The results from the tail-suspension test paralleled those from the forced swim test except that chronic footshock tended to decrease the time spent immobile. Thus in rats, the behavioral effects of the chronic footshock in the forced swim test could be explained by a desensitization of the CRF systems, either decreased activation of CRF, or desensitization of its receptors. However, such an effect cannot explain the responses to restraint, nor the behavioral effects of chronic footshock and restraint in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120099     DOI: 10.1196/annals.1410.022

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

Review 2.  The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.

Authors:  Adrian J Dunn; Artur H Swiergiel
Journal:  Eur J Pharmacol       Date:  2008-01-26       Impact factor: 4.432

3.  Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

Authors:  Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

Review 4.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

5.  Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor.

Authors:  Susan K Wood; Kile V McFadden; Dimitri Grigoriadis; Seema Bhatnagar; Rita J Valentino
Journal:  Psychopharmacology (Berl)       Date:  2012-02-10       Impact factor: 4.530

6.  Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor.

Authors:  Susan K Wood; Hayley E Walker; Rita J Valentino; Seema Bhatnagar
Journal:  Endocrinology       Date:  2010-02-16       Impact factor: 4.736

7.  Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress.

Authors:  Susan K Wood; Xiao-Yan Zhang; Beverly A S Reyes; Catherine S Lee; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

8.  Acute illness-induced behavioral alterations are similar to those observed during withdrawal from acute alcohol exposure.

Authors:  Laura Richey; Tamara L Doremus-Fitzwater; Hollin M Buck; Terrence Deak
Journal:  Pharmacol Biochem Behav       Date:  2012-08-17       Impact factor: 3.533

9.  Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice.

Authors:  Nathalie Alvarez-Ricartes; Patricia Oliveros-Matus; Cristhian Mendoza; Nelson Perez-Urrutia; Florencia Echeverria; Alexandre Iarkov; George E Barreto; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

10.  Chronic Sulfasalazine Treatment in Mice Induces System xc - - Independent Adverse Effects.

Authors:  Lise Verbruggen; Lindsay Sprimont; Eduard Bentea; Pauline Janssen; Azzedine Gharib; Lauren Deneyer; Laura De Pauw; Olaya Lara; Hideyo Sato; Charles Nicaise; Ann Massie
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.